Ledermann, Jonathan A
El-Khouly, Fatima
Article History
First Online: 15 December 2015
Competing interests
: Professor Ledermann: Lead international investigator of Study 19, proposing the design of the trial, has participated in Advisory Boards for AstraZeneca and Clovis without remuneration, is a member of the Trial Steering Committee for the Phase III trial with niraparib (Tesaro), and is the co-lead investigator for ARIEL-3 (Clovis). Dr El-Khouly: none.